COVID - 19: Clinical Trials

5 trials for COVID - 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 withdrawn. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 2, Withdrawn 1
Phase 12Completed 2

Follow COVID - 19: new trials by email Literature Review of COVID - 19 trials Research Report on COVID - 19

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
Ratutrelvir (83-0060) non-randomised, Paxlovid, Ratutrelvir (83-0060) - COVID - 19
Phase 2RecruitingTraws Pharma, Inc.902025-09-162026-01-21
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Remdesivir (RDV) - COVID - 19, Renal Transplant
Phase 2RecruitingFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia152025-09-012025-09-29
EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL
Colchicine 0.5 MG Oral Tablet - COVID - 19
Phase 1 / Phase 2CompletedZaeema Kanwal662025-02-242025-09-04
Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG
SpiN-Tec MCTI UFMG, Active Comparator: Covishield® vaccine, Active Comparator: Comirnaty® vaccine - COVID - 19
Phase 1 / Phase 2CompletedFederal University of Minas Gerais4322022-11-232025-09-15
A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19
TCB008 - COVID - 19
Phase 2WithdrawnTC Biopharm2021-12-132023-04-21

Narrower conditions

COVID-19 (5)  ·  Communicable Diseases (1)  ·  Coronavirus Infections (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Broader conditions

Coronaviridae Infections (5)  ·  Infections (5)  ·  Lung Diseases (5)  ·  Nidovirales Infections (5)  ·  Pneumonia (5)  ·  Pneumonia, Viral (5)  ·  RNA Virus Infections (5)  ·  Respiratory Tract Diseases (5)  ·  Coronavirus Infections (4)  ·  Respiratory Tract Infections (4)  ·  Virus Diseases (4)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Colchicine (1)  ·  Tablets (1)  ·  nirmatrelvir and ritonavir drug combination (1)  ·  remdesivir (1)

Sponsors

Federal University of Minas Gerais (1)  ·  Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)  ·  TC Biopharm (1)  ·  Traws Pharma, Inc. (1)  ·  Zaeema Kanwal (1)

Countries

Australia (1)  ·  Brazil (1)  ·  Pakistan (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  Uzbekistan (1)

Top investigators

Ricardo T Gazzinelli, DVM, PhD (1)